恩扎鲁胺
前列腺癌
癌症
医学
前列腺
肿瘤科
内科学
癌症研究
雄激素受体
作者
Neal D. Shore,Murilo Luz,Ugo De Giorgi,Martin Gleave,Geoffrey Gotto,Christopher Pieczonka,Gabriel P. Haas,Choung‐Soo Kim,M. Backhaus,Antti Rannikko,Matko Kalac,Swetha Sridharan,Matt Rosales,Yiyun Tang,Ronald Tutrone,Balaji Venugopal,Arnauld Villers,Henry H. Woo,Fong Wang,Stephen J. Freedland
标识
DOI：10.1056/nejmoa2510310
摘要
Overall survival was significantly longer with the combination of enzalutamide and leuprolide than with leuprolide alone among patients with prostate cancer with high-risk biochemical recurrence. Enzalutamide monotherapy was not superior to leuprolide alone in the analysis of overall survival. (Funded by Pfizer and Astellas Pharma; EMBARK ClinicalTrials.gov number, NCT02319837.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
BowieHuang
无极微光
你嵙这个期刊没买
smottom
快乐滑板
GingerF
闪闪的诗珊
Criminology34
Twonej
toutou
pcr163
轨迹
幽壑之潜蛟
专注的问寒
ilihe
pluto
zhonglv7
tuanheqi
带头大哥
QingS
调皮的酬海
寻道图强
沉默的倔驴
劉浏琉
皖公网安备34019202002308
